Skip to main content


SNO Guidelines Endorsement 

The Society for Neuro-Oncology recognizes that other professional organizations may from time to time develop guidelines that would benefit the membership of SNO. The SNO Guidelines Committee is committed to systematically evaluating these documents and disseminating these documents to its membership as appropriate.

SNO will consider endorsement of clinical practice guidelines initiated by other professional organizations when relevant and appropriate to the mission and interests of SNO and its membership.

To read the SNO Guidelines Endorsement criteria, click here.

SNO has officially endorsed the following guidelines:

Treatment for Brain Metastases:  ASCO/SNO/ASTRO Guidelines
Published December 21, 2021 Journal of Clinical Oncology.  To view the publication, click here.    

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults:  ASCO-SNO Guidelines
Published December 13, 2021 Journal of Clinical Oncology.  To view the publication, click here

SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors 
To view the update, click here

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas  
Endorsed 6/18/21. To view the publication, click here.  

SNO/EANO consensus review Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. 
Published in Neuro-Oncology January 20, 2021.  To view consensus review, click here.

Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline
To view the ASTRO manuscript, click here.

Neuro-Oncology Patient Survivorship Care Plan
To view the Care Plan, click here.

Neuro-Oncology Quality Measurement Set
Published in Neuro-Oncology March 2, 2018.  To view the publication, click here.